Optimising maintenance therapy after transplantation: sorafenib's role in patients with FLT3-ITD acute myeloid leukaemia

Musa Yilmaz; Naval Daver

doi:10.1016/S2352-3026(23)00213-2

Optimising maintenance therapy after transplantation: sorafenib's role in patients with FLT3-ITD acute myeloid leukaemia

Leukemia

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	e559-e561
Journal	The Lancet Haematology
Volume	10
Issue number	8
DOIs	https://doi.org/10.1016/S2352-3026(23)00213-2
State	Published - Aug 2023

ASJC Scopus subject areas

Hematology

Access to Document

10.1016/S2352-3026(23)00213-2

Cite this

@article{09b1dacf757c4598bfa370c2466037c3,

title = "Optimising maintenance therapy after transplantation: sorafenib's role in patients with FLT3-ITD acute myeloid leukaemia",

author = "Musa Yilmaz and Naval Daver",

year = "2023",

month = aug,

doi = "10.1016/S2352-3026(23)00213-2",

language = "English (US)",

volume = "10",

pages = "e559--e561",

journal = "The Lancet Haematology",

issn = "2352-3026",

publisher = "Lancet Publishing Group",

number = "8",

}

TY - JOUR

T1 - Optimising maintenance therapy after transplantation

T2 - sorafenib's role in patients with FLT3-ITD acute myeloid leukaemia

AU - Yilmaz, Musa

AU - Daver, Naval

PY - 2023/8

Y1 - 2023/8

UR - http://www.scopus.com/inward/record.url?scp=85166408244&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85166408244&partnerID=8YFLogxK

U2 - 10.1016/S2352-3026(23)00213-2

DO - 10.1016/S2352-3026(23)00213-2

M3 - Comment/debate

C2 - 37532412

AN - SCOPUS:85166408244

SN - 2352-3026

VL - 10

SP - e559-e561

JO - The Lancet Haematology

JF - The Lancet Haematology

IS - 8

ER -

Optimising maintenance therapy after transplantation: sorafenib's role in patients with FLT3-ITD acute myeloid leukaemia

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this